Duk-soo K. Bae
Expertise in
6
conditions

Duk-soo K. Bae

Seoul, KR 
Expertise in
6
conditions
Seoul, KR 

Overview

Duk-soo Bae practices practicing medicine in Seoul, Republic of Korea.

Mr. Bae is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Ovarian Cancer, Uterine Fibroids, Hysterectomy, and Lymphadenectomy.

He is actively involved in clinical research, co-authoring 149 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Seoul, Republic of Korea
Other Locations
Changwon, Republic of Korea
Ulsan, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
Enrollment Status: Active_not_recruiting
Publish Date: December 30, 2025
Intervention Type: Other, Drug, Biological
Study Drugs: Bevacizumab, Carboplatin, Docetaxel, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 3

149 Total Publications

Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.
Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.
Journal: Frontiers in immunology
Published: January 16, 2024

Frequently Asked Questions about Duk-soo K. Bae

Is Duk-soo K. Bae a top-rated expert for Hysterectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Duk-soo K. Bae is classified as an Advanced expert for Hysterectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Duk-soo K. Bae participate in research or clinical trials?

Yes. Duk-soo K. Bae has published 149 articles and abstracts on conditions like Hysterectomy. You can view a list of Duk-soo K. Bae's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bae's expertise for a condition
ConditionClose
      View All 22 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile